DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia

Clinical trial NCT00241488 · COMPLETED

Trial details

NCT number: NCT00241488
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypercholesterolemia

Start date: 2003-06-01
Primary completion: 2005-12-01
Enrollment: 1362

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.